Characterization shows biocompatibility and effectiveness of alginate and β-tricalcium phosphate in bone treatment.
The freeze-drying procedure was used to create the scaffold that was meant to cure bone deformities. Fourier transform infrared (FTIR) spectroscopy, X-ray diffraction analysis, swelling and degradation ratio, and scanning electron microscopy (SEM) tests were used to characterize the scaffolds. Osteoblast cells were used in an in vitro cytotoxicity test to evaluate the scaffolds' biocompatibility. The results of the characterization revealed an interconnected porous structure and significant ionic connections between the alginate, egg-shell membrane, and β-tricalcium phosphate (β-TCP). The scaffolds are regarded as nontoxic because the cell viability was more than 80%. When all the findings are evaluated, β-TCP with alginate/egg-shell membrane can be regarded as appropriate for bone treatment applications.
No takes yet. Share an insight, caveat, or question.
Semra Ünal (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: